Flu Vaccine (Influenza Vaccine)  Market Report

Global Flu Vaccine (Influenza Vaccine) Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 23, 2022
  • PAGES：221
  • REPORT CODE：GMM766405
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Flu Vaccine (Influenza Vaccine) market report explains the definition, types, applications, major countries, and major players of the Flu Vaccine (Influenza Vaccine) market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • AstraZeneca

    • Mylan

    • Johnson & Johnson

    • CSL

    • Sanofi Pasteur

    • GSK

    • Pfizer

    By Type:

    • Whole Virus Vaccines

    • Split Virus Vaccines

    • Subunit Vaccines

    • Live Attenuated Virus Vaccines

    By End-User:

    • For Children (6 months to 3 years)

    • For Adults and Children over 3 years

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Flu Vaccine (Influenza Vaccine) Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Flu Vaccine (Influenza Vaccine) Outlook to 2028- Original Forecasts

    • 2.2 Flu Vaccine (Influenza Vaccine) Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Flu Vaccine (Influenza Vaccine) Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Flu Vaccine (Influenza Vaccine) Market- Recent Developments

    • 6.1 Flu Vaccine (Influenza Vaccine) Market News and Developments

    • 6.2 Flu Vaccine (Influenza Vaccine) Market Deals Landscape

    7 Flu Vaccine (Influenza Vaccine) Raw Materials and Cost Structure Analysis

    • 7.1 Flu Vaccine (Influenza Vaccine) Key Raw Materials

    • 7.2 Flu Vaccine (Influenza Vaccine) Price Trend of Key Raw Materials

    • 7.3 Flu Vaccine (Influenza Vaccine) Key Suppliers of Raw Materials

    • 7.4 Flu Vaccine (Influenza Vaccine) Market Concentration Rate of Raw Materials

    • 7.5 Flu Vaccine (Influenza Vaccine) Cost Structure Analysis

      • 7.5.1 Flu Vaccine (Influenza Vaccine) Raw Materials Analysis

      • 7.5.2 Flu Vaccine (Influenza Vaccine) Labor Cost Analysis

      • 7.5.3 Flu Vaccine (Influenza Vaccine) Manufacturing Expenses Analysis

    8 Global Flu Vaccine (Influenza Vaccine) Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Flu Vaccine (Influenza Vaccine) Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Flu Vaccine (Influenza Vaccine) Export by Region (Top 10 Countries) (2017-2028)

    9 Global Flu Vaccine (Influenza Vaccine) Market Outlook by Types and Applications to 2022

    • 9.1 Global Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Whole Virus Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Split Virus Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Subunit Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Live Attenuated Virus Vaccines Consumption and Growth Rate (2017-2022)

    • 9.2 Global Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global For Children (6 months to 3 years) Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global For Adults and Children over 3 years Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Flu Vaccine (Influenza Vaccine) Market Analysis and Outlook till 2022

    • 10.1 Global Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.2.2 Canada Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.2.3 Mexico Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.3.2 UK Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.3.3 Spain Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.3.4 Belgium Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.3.5 France Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.3.6 Italy Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.3.7 Denmark Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.3.8 Finland Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.3.9 Norway Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.3.10 Sweden Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.3.11 Poland Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.3.12 Russia Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.3.13 Turkey Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.4.2 Japan Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.4.3 India Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.4.4 South Korea Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.4.5 Pakistan Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.4.6 Bangladesh Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.4.7 Indonesia Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.4.8 Thailand Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.4.9 Singapore Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.4.10 Malaysia Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.4.11 Philippines Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.4.12 Vietnam Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.5.2 Colombia Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.5.3 Chile Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.5.4 Argentina Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.5.5 Venezuela Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.5.6 Peru Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.5.7 Puerto Rico Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.5.8 Ecuador Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.6.2 Kuwait Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.6.3 Oman Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.6.4 Qatar Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.7.2 South Africa Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.7.3 Egypt Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.7.4 Algeria Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

      • 10.8.2 New Zealand Flu Vaccine (Influenza Vaccine) Consumption (2017-2022)

    11 Global Flu Vaccine (Influenza Vaccine) Competitive Analysis

    • 11.1 AstraZeneca

      • 11.1.1 AstraZeneca Company Details

      • 11.1.2 AstraZeneca Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 AstraZeneca Flu Vaccine (Influenza Vaccine) Main Business and Markets Served

      • 11.1.4 AstraZeneca Flu Vaccine (Influenza Vaccine) Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Mylan

      • 11.2.1 Mylan Company Details

      • 11.2.2 Mylan Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Mylan Flu Vaccine (Influenza Vaccine) Main Business and Markets Served

      • 11.2.4 Mylan Flu Vaccine (Influenza Vaccine) Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Johnson & Johnson

      • 11.3.1 Johnson & Johnson Company Details

      • 11.3.2 Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Johnson & Johnson Flu Vaccine (Influenza Vaccine) Main Business and Markets Served

      • 11.3.4 Johnson & Johnson Flu Vaccine (Influenza Vaccine) Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 CSL

      • 11.4.1 CSL Company Details

      • 11.4.2 CSL Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 CSL Flu Vaccine (Influenza Vaccine) Main Business and Markets Served

      • 11.4.4 CSL Flu Vaccine (Influenza Vaccine) Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Sanofi Pasteur

      • 11.5.1 Sanofi Pasteur Company Details

      • 11.5.2 Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Main Business and Markets Served

      • 11.5.4 Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 GSK

      • 11.6.1 GSK Company Details

      • 11.6.2 GSK Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 GSK Flu Vaccine (Influenza Vaccine) Main Business and Markets Served

      • 11.6.4 GSK Flu Vaccine (Influenza Vaccine) Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Pfizer

      • 11.7.1 Pfizer Company Details

      • 11.7.2 Pfizer Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Pfizer Flu Vaccine (Influenza Vaccine) Main Business and Markets Served

      • 11.7.4 Pfizer Flu Vaccine (Influenza Vaccine) Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    12 Global Flu Vaccine (Influenza Vaccine) Market Outlook by Types and Applications to 2028

    • 12.1 Global Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Whole Virus Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Split Virus Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Subunit Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Live Attenuated Virus Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global For Children (6 months to 3 years) Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global For Adults and Children over 3 years Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Flu Vaccine (Influenza Vaccine) Market Analysis and Outlook to 2028

    • 13.1 Global Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.2.2 Canada Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.3.2 UK Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.3.3 Spain Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.3.5 France Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.3.6 Italy Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.3.8 Finland Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.3.9 Norway Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.3.11 Poland Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.3.12 Russia Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.4.2 Japan Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.4.3 India Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.5.3 Chile Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.5.6 Peru Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.6.3 Oman Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Flu Vaccine (Influenza Vaccine) Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Flu Vaccine (Influenza Vaccine)

    • Figure of Flu Vaccine (Influenza Vaccine) Picture

    • Table Global Flu Vaccine (Influenza Vaccine) Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Flu Vaccine (Influenza Vaccine) Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Whole Virus Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Split Virus Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Subunit Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Live Attenuated Virus Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global For Children (6 months to 3 years) Consumption and Growth Rate (2017-2022)

    • Figure Global For Adults and Children over 3 years Consumption and Growth Rate (2017-2022)

    • Figure Global Flu Vaccine (Influenza Vaccine) Consumption by Country (2017-2022)

    • Table North America Flu Vaccine (Influenza Vaccine) Consumption by Country (2017-2022)

    • Figure United States Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Canada Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Mexico Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Table Europe Flu Vaccine (Influenza Vaccine) Consumption by Country (2017-2022)

    • Figure Germany Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure UK Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Spain Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Belgium Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure France Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Italy Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Denmark Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Finland Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Norway Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Sweden Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Poland Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Russia Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Turkey Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Table APAC Flu Vaccine (Influenza Vaccine) Consumption by Country (2017-2022)

    • Figure China Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Japan Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure India Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Thailand Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Singapore Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Philippines Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Table South America Flu Vaccine (Influenza Vaccine) Consumption by Country (2017-2022)

    • Figure Brazil Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Colombia Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Chile Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Argentina Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Peru Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Table GCC Flu Vaccine (Influenza Vaccine) Consumption by Country (2017-2022)

    • Figure Bahrain Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Oman Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Qatar Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Table Africa Flu Vaccine (Influenza Vaccine) Consumption by Country (2017-2022)

    • Figure Nigeria Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure South Africa Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Egypt Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure Algeria Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Table Oceania Flu Vaccine (Influenza Vaccine) Consumption by Country (2017-2022)

    • Figure Australia Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Flu Vaccine (Influenza Vaccine) Consumption and Growth Rate (2017-2022)

    • Table AstraZeneca Company Details

    • Table AstraZeneca Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Flu Vaccine (Influenza Vaccine) Main Business and Markets Served

    • Table AstraZeneca Flu Vaccine (Influenza Vaccine) Product Portfolio

    • Table Mylan Company Details

    • Table Mylan Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Flu Vaccine (Influenza Vaccine) Main Business and Markets Served

    • Table Mylan Flu Vaccine (Influenza Vaccine) Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Flu Vaccine (Influenza Vaccine) Main Business and Markets Served

    • Table Johnson & Johnson Flu Vaccine (Influenza Vaccine) Product Portfolio

    • Table CSL Company Details

    • Table CSL Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Flu Vaccine (Influenza Vaccine) Main Business and Markets Served

    • Table CSL Flu Vaccine (Influenza Vaccine) Product Portfolio

    • Table Sanofi Pasteur Company Details

    • Table Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Main Business and Markets Served

    • Table Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Product Portfolio

    • Table GSK Company Details

    • Table GSK Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Flu Vaccine (Influenza Vaccine) Main Business and Markets Served

    • Table GSK Flu Vaccine (Influenza Vaccine) Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Flu Vaccine (Influenza Vaccine) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Flu Vaccine (Influenza Vaccine) Main Business and Markets Served

    • Table Pfizer Flu Vaccine (Influenza Vaccine) Product Portfolio

    • Figure Global Whole Virus Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Split Virus Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Subunit Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Live Attenuated Virus Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global For Children (6 months to 3 years) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global For Adults and Children over 3 years Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Flu Vaccine (Influenza Vaccine) Consumption Forecast by Country (2022-2028)

    • Table North America Flu Vaccine (Influenza Vaccine) Consumption Forecast by Country (2022-2028)

    • Figure United States Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Flu Vaccine (Influenza Vaccine) Consumption Forecast by Country (2022-2028)

    • Figure Germany Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Flu Vaccine (Influenza Vaccine) Consumption Forecast by Country (2022-2028)

    • Figure China Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Flu Vaccine (Influenza Vaccine) Consumption Forecast by Country (2022-2028)

    • Figure Brazil Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Flu Vaccine (Influenza Vaccine) Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Flu Vaccine (Influenza Vaccine) Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Flu Vaccine (Influenza Vaccine) Consumption Forecast by Country (2022-2028)

    • Figure Australia Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Flu Vaccine (Influenza Vaccine) Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US